A Review of the Role of Intravitreal Corticosteroids as an Adjuvant to Antibiotics in Infectious Endophthalmitis
Infectious endophthalmitis is an important cause of vision loss worldwide. This entity most often occurs as a complication of intraocular surgery especially following cataract surgery or intravitreal injection. Endophthalmitis is regarded as a serious complication following ocular surgery and the final visual outcome is fundamentally contingent on timely recognition and intervention. Intravitreal and oral antibiotics in combination with pars plana vitrectomy or vitreous aspiration remain the mainstay in the management of endophthalmitis. However, significant inflammation may persist even after sterilization of the intraocular cavities with appropriate antibiotics resulting in failure of treatment. This forms the basis for the use of intravitreal corticosteroids as an adjuvant to antibiotics in the management of infectious endophthalmitis. In the index manuscript, we review the existing literature to determine the role of intravitreal corticosteroids as an adjuvant to antibiotics in treating infectious endophthalmitis, and discuss their beneficial effects and controversial concerns.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Ocular immunology and inflammation - 26(2018), 3 vom: 01., Seite 461-468 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ching Wen Ho, Dawn [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 20.07.2018 Date Revised 08.10.2019 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/09273948.2016.1245758 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM266236391 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM266236391 | ||
003 | DE-627 | ||
005 | 20231224214043.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/09273948.2016.1245758 |2 doi | |
028 | 5 | 2 | |a pubmed24n0887.xml |
035 | |a (DE-627)NLM266236391 | ||
035 | |a (NLM)27849402 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ching Wen Ho, Dawn |e verfasserin |4 aut | |
245 | 1 | 2 | |a A Review of the Role of Intravitreal Corticosteroids as an Adjuvant to Antibiotics in Infectious Endophthalmitis |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.07.2018 | ||
500 | |a Date Revised 08.10.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Infectious endophthalmitis is an important cause of vision loss worldwide. This entity most often occurs as a complication of intraocular surgery especially following cataract surgery or intravitreal injection. Endophthalmitis is regarded as a serious complication following ocular surgery and the final visual outcome is fundamentally contingent on timely recognition and intervention. Intravitreal and oral antibiotics in combination with pars plana vitrectomy or vitreous aspiration remain the mainstay in the management of endophthalmitis. However, significant inflammation may persist even after sterilization of the intraocular cavities with appropriate antibiotics resulting in failure of treatment. This forms the basis for the use of intravitreal corticosteroids as an adjuvant to antibiotics in the management of infectious endophthalmitis. In the index manuscript, we review the existing literature to determine the role of intravitreal corticosteroids as an adjuvant to antibiotics in treating infectious endophthalmitis, and discuss their beneficial effects and controversial concerns | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Antibiotics | |
650 | 4 | |a antifungals | |
650 | 4 | |a corticosteroids | |
650 | 4 | |a endophthalmitis | |
650 | 4 | |a intravitreal steroids | |
650 | 4 | |a intravitreal therapy | |
650 | 4 | |a uveitis | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Antifungal Agents |2 NLM | |
650 | 7 | |a Glucocorticoids |2 NLM | |
700 | 1 | |a Agarwal, Aniruddha |e verfasserin |4 aut | |
700 | 1 | |a Lee, Cecilia S |e verfasserin |4 aut | |
700 | 1 | |a Chhablani, Jay |e verfasserin |4 aut | |
700 | 1 | |a Gupta, Vishali |e verfasserin |4 aut | |
700 | 1 | |a Khatri, Manoj |e verfasserin |4 aut | |
700 | 1 | |a Nirmal, Jayabalan |e verfasserin |4 aut | |
700 | 1 | |a Pavesio, Carlos |e verfasserin |4 aut | |
700 | 1 | |a Agrawal, Rupesh |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ocular immunology and inflammation |d 1993 |g 26(2018), 3 vom: 01., Seite 461-468 |w (DE-627)NLM091014069 |x 1744-5078 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2018 |g number:3 |g day:01 |g pages:461-468 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/09273948.2016.1245758 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2018 |e 3 |b 01 |h 461-468 |